New study highlights low recurrence rates after colorectal FTRD®

FTRD® shows low recurrence rates and high success in treating difficult colorectal lesions

Key findings

• Colorectal FTRD® demonstrates a low overall recurrence rate of 9.9% (n=9/91)
• Majority (66.6%) of recurrent or residual lesions (RRLs) were successfully treated endoscopically. All of them occurred in non-lifting adenoma
• No late adverse events reported
• Close follow-up is crucial for optimal outcomes, especially in non-lifting adenomas and early carcinomas

Study details

• Retrospective analysis conducted at University Medical Center Freiburg from 2014 to 2021.
• Included 91 patients with at least one endoscopic follow-up examination.
• Indications for FTRD®: Non-lifting adenoma (n=65), subepithelial tumors (n=18), early carcinoma (n=8).
• Median follow-up period was 17 months (range 2-86)

Mueller J, Miedtke V, Kuellmer A, Schiemer M, Bettinger D, Thimme R, Schmidt A. Outcome after colorectal full-thickness resection and management of recurrence. Endosc Int Open. 2024;12(8):E989-E995. DOI: 10.1055/a-2375-7568.